Solid Biosciences Inc. (SLDB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 493.53M |
| Enterprise Value | 454.79M |
| P/E Ratio | -4.25 |
| PEG Ratio | -0.17 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.36 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.47 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.55 |
| Return On Equity | -0.68 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.64M |
| EBITDA | -172.69M |
| Net Income | -174.33M |
| Diluted EPS | -1.99 |
| Total Cash | 348.93M |
| Total Cash/Share | 2.31 |
| Total Debt | 19.62M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 11.99 |
| Book Value Per Share | 2.27 |
| 52-Week Change | 67.77 |
| 52-Week High | 11.45 |
| 52-Week Low | 4.16 |
| Moving Average 50 Days | 7.38 |
| Moving Average 200 Days | 7.68 |
| Average Volume | 1.23M |
| Shares Outstanding | 111.61M |
| % Held by Institutions | 79.89 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | October 28, 2022 |